5'-Chloro-2'-hydroxy-3'-nitroacetophenone, 99.0%, 25g

tert-Butyl 4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-5-6-dihydropyridine-1(2H)-carboxylate, 98.0%, 100g

N-Phenyl-1H-1,3-benzodiazole-2-carboxamide, 25mg

4-(((3,3-Dimethylbutan-2-yl)amino)methyl)benzoic acid, 98%, 100mg

4-Fluorophenylacetonitrile, 97.00%, 250g

Esculetin [Matrix for MALDI-TOF/MS]>99.0%(HPLC)(T)200mg

3-(3-Chloro-5-fluorophenyl)-1-propene, 97.0%, 1g

(3R)-1-Benzhydryl-2,2-dimethyl-azetidin-3-ol, 97%, 100mg

4-[(4-Methylphenyl)sulfonyl]piperidinehydrochloride, 95.0%, 1g

1-Bromo-2,4-dinitrobenzene, 95%, 50g

4-Amino-2-fluorobenzoic acid, 98.0%, 25g

4-Bromo-4'-pentyl-1,1'-biphenyl, 95.0%, 25g

tert-Butyl (4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-2-yl)carbamate, 95.0%, 250mg